510(k) · Cleared
ClearedGlucose Control Solution for Chdiagnostics Senova, Chdignostics Senova Blood Glucose Test System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bionostics, Inc. · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)
Cleared on Oct 20, 2003 as substantially equivalent to K012430 (Bionostics, Inc., 2001) after a 40-day review. Its family tree reaches back 2 generations to 1993.
- Decided
- Oct 20, 2003
- Review
- 40 days
- Class
- Class I
- Product code
- JJX
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 2 generations to K925479 (1993). 3 ancestors in all. No later device cites it as a predicate yet.
- Root · 2 generations backK925479 Sugar Chex Linearity for the One TouchStreck Laboratories, Inc. · 1993
- 1 generation backK012430 Multi-Meter Glucose Calibration Verification Material, Model Rna GL3Bionostics, Inc. · 2001
- This deviceK032819 Glucose Control Solution for Chdiagnostics Senova, Chdignostics…Bionostics, Inc. · 2003
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K925479 | Sugar Chex Linearity for the One Touch | Streck Laboratories, Inc. | 1993 | — |
| −1 | K012430 | Multi-Meter Glucose Calibration Verification Material, Model Rna GL3 | Bionostics, Inc. | 2001 | — |
| 0 (this device) | K032819 | Glucose Control Solution for Chdiagnostics Senova, Chdignostics Senova Blood… | Bionostics, Inc. | 2003 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K012430 | Multi-Meter Glucose Calibration Verification Material, Model Rna GL3Summary page 1…Glucose Control Solution for Verification Material CHDiagnostics Senova 510(k), Date: K012430,08/27/01 Number of levels: 5 3 Analytes:… | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 8.6 years on median.
- None of the 3 ancestors has a recall.
- 3 other devices also cite its predicate K012430.
How does its category compare?
All JJX devicesJJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JJX
2in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · JJX
31in 2016
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JJX
1in 2021
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JJX
22in 2025
MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 53 | 3 | 2 |
| 2008 | 8 | 52 | 3 | 0 |
| 2009 | 17 | 80 | 0 | 1 |
| 2010 | 24 | 80 | 3 | 6 |
| 2011 | 19 | 62 | 2 | 62 |
| 2012 | 15 | 40 | 0 | 32 |
| 2013 | 19 | 37 | 0 | 51 |
| 2014 | 22 | 30 | 1 | 48 |
| 2015 | 11 | 65 | 1 | 67 |
| 2016 | 6 | 31 | 2 | 37 |
| 2017 | 2 | — | 0 | 19 |
| 2018 | 0 | — | 2 | 35 |
| 2019 | 0 | — | 0 | 82 |
| 2020 | 0 | — | 0 | 77 |
| 2021 | 0 | — | 1 | 43 |
| 2022 | 0 | — | 0 | 24 |
| 2023 | 0 | — | 0 | 22 |
| 2024 | 0 | — | 0 | 30 |
| 2025 | 0 | — | 0 | 22 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Glucose Control Solution for Chdiagnostics Senova'" Blood Glucose Monitoring System is intended for use to verify the performance of the Chdiagnostics Senova'" BGM System at glucose levels within the reportable range. The Glucose Control Solution is intended for use by healthcare professionals and people with diabetes mellitus at home.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K032819 · printed Nov 4, 2026
Cite this page
510(k) Report. “K032819: Glucose Control Solution for Chdiagnostics Senova, Chdignostics Senova Blood Glucose Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K032819
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026